{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:21:25Z","timestamp":1787678485538,"version":"build-2784847793"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007046","name":"Wuhan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110129","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:21:54Z","timestamp":1781763714000},"page":"110129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A novel ER\u03b1-targeted hydrophobic tag degrader, overcomes tamoxifen resistance via unfolded protein response-induced apoptosis and homologous recombination repair inhibition in breast cancer"],"prefix":"10.1016","volume":"180","author":[{"given":"Rong","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilan","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangkang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Bing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110129_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110129_bb0010","first-page":"10","article-title":"Cancer statistics, 2025","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110129_bb0015","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1007\/s11033-022-07571-2","article-title":"Breast cancer in the era of precision medicine","author":"Sarhangi","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bioorg.2026.110129_bb0020","doi-asserted-by":"crossref","first-page":"898","DOI":"10.20892\/j.issn.2095-3941.2024.0224","article-title":"Intricate roles of estrogen and estrogen receptors in digestive system cancers: a systematic review","author":"Gan","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.bioorg.2026.110129_bb0025","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/cac2.12358","article-title":"Breast cancer: an up-to-date review and future perspectives","author":"Hong","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bioorg.2026.110129_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107607","article-title":"Aromatase inhibitors for the treatment of breast cancer: an overview (2019\u20132023)","author":"Bhatia","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110129_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.12.012","article-title":"Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment","author":"Patel","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2026.110129_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-89274-9","article-title":"Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer","author":"Jones","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110129_bb0045","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","article-title":"Overcoming endocrine resistance in breast Cancer","author":"Hanker","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2026.110129_bb0050","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41568-023-00604-3","article-title":"Therapeutic resistance to anti-oestrogen therapy in breast cancer","author":"Will","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.110129_bb0055","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00109-021-02136-5","article-title":"Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies","author":"Saatci","year":"2021","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bioorg.2026.110129_bb0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/ijms14010108","article-title":"Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance","author":"Garcia-Becerra","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110129_bb0065","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1158\/1078-0432.CCR-17-3702","article-title":"Comprehensive profiling of DNA repair defects in breast Cancer identifies a novel class of endocrine therapy resistance drivers","author":"Anurag","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110129_bb0070","doi-asserted-by":"crossref","first-page":"36252","DOI":"10.18632\/oncotarget.26363","article-title":"DNA damage repair defects as a new class of endocrine treatment resistance driver","author":"Anurag","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2026.110129_bb0075","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41467-018-03951-0","article-title":"Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1","author":"Zhu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110129_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00140","article-title":"Unfolding the role of stress response signaling in endocrine resistant breast cancers","author":"Clarke","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2026.110129_bb0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2020.05.020","article-title":"Targeting the IRE1-XBP1 axis to overcome endocrine resistance in breast cancer: opportunities and challenges","author":"Barua","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2026.110129_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115741","article-title":"Hydrophobic tag-based protein degradation: development, opportunity and challenge","author":"He","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110129_bb0095","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.1021\/acs.jmedchem.2c00257","article-title":"Discovery of small-molecule degraders of the CDK9-cyclin T1 complex for targeting transcriptional addiction in prostate Cancer","author":"Li","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110129_bb0100","doi-asserted-by":"crossref","first-page":"10917","DOI":"10.1021\/acs.jmedchem.3c00736","article-title":"Small-molecule hydrophobic tagging: a promising strategy of druglike Technology for Targeted Protein Degradation","author":"Xie","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110129_bb0105","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/cbic.201100793","article-title":"Identification of hydrophobic tags for the degradation of stabilized proteins","author":"Tae","year":"2012","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bioorg.2026.110129_bb0110","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.chembiol.2017.05.024","article-title":"Targeted protein degradation: from chemical biology to drug discovery","author":"Cromm","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110129_bb0115","article-title":"LPM3770277, a potent novel CDK4\/6 degrader, exerts antitumor effect against triple-negative breast Cancer","author":"Qiu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110129_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.109192","article-title":"Hydrophobic tag tethering degrader as a promising paradigm of protein degradation: past, present and future perspectives","author":"Ha","year":"2024","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110129_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106599","article-title":"OBHSA, a novel selective estrogen receptor degrader, overcomes tamoxifen resistance through cell cycle arrest and unfolded protein response-mediated apoptosis in breast cancer","author":"Shen","year":"2024","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110129_bb0130","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1016\/j.apsb.2023.05.005","article-title":"Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer","volume":"13","author":"Wang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110129_bb0135","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. Sect. D"},{"issue":"12 Part 1","key":"10.1016\/j.bioorg.2026.110129_bb0140","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1107\/S0907444904023510","article-title":"REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use","volume":"60","author":"Vagin","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bioorg.2026.110129_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115741","article-title":"Hydrophobic tag-based protein degradation: development, opportunity and challenge","author":"He","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110129_bb0150","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1021\/acs.jmedchem.4c02269","article-title":"Discovery of D-ring-contracted artemisinin as a potent hydrophobic tag for targeted protein degradation","author":"Qing","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110129_bb0155","doi-asserted-by":"crossref","first-page":"8339","DOI":"10.1021\/acs.jmedchem.3c00136","article-title":"Targeting the estrogen receptor for the treatment of breast cancer: recent advances and challenges","author":"Rej","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110129_bb0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/or.2014.3190","article-title":"Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (review)","author":"Viedma-Rodriguez","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bioorg.2026.110129_bb0165","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.2147\/CMAR.S173193","article-title":"Clinical value of circulating ESR1 mutations for patients with metastatic breast cancer: a meta-analysis","author":"Zhang","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bioorg.2026.110129_bb0170","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1002\/cncr.32345","article-title":"ESR1 mutations in breast cancer","author":"Dustin","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.bioorg.2026.110129_bb0175","article-title":"Discovery of norbornene as a novel hydrophobic tag applied in protein degradation","author":"Xie","year":"2023","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bioorg.2026.110129_bb0180","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","article-title":"Mechanisms, regulation and functions of the unfolded protein response","author":"Hetz","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110129_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/biology10050384","article-title":"The unfolded protein response: an overview","author":"Read","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.bioorg.2026.110129_bb0190","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/annonc\/mdy099","article-title":"RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer","author":"Cruz","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bioorg.2026.110129_bb0195","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1158\/0008-5472.CAN-21-2409","article-title":"Preclinical in vivo validation of the RAD51 test for identification of homologous recombination-deficient tumors and patient stratification","author":"Pellegrino","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110129_bb0200","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1038\/s41467-022-34911-4","article-title":"The non-catalytic role of DNA polymerase epsilon in replication initiation in human cells","author":"Vipat","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110129_bb0205","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/leu.2010.6","article-title":"gammaH2AX: a sensitive molecular marker of DNA damage and repair","author":"Mah","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.bioorg.2026.110129_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116663","article-title":"H2AX: a key player in DNA damage response and a promising target for cancer therapy","author":"Prabhu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.110129_bb0215","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/jcb.20640","article-title":"Cellular localization of human Rad51C and regulation of ubiquitin-mediated proteolysis of Rad51","author":"Bennett","year":"2005","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bioorg.2026.110129_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2023.119526","article-title":"Stability of Rad51 recombinase and persistence of Rad51 DNA repair foci depends on post-translational modifiers, ubiquitin and SUMO","author":"Antoniuk-Majchrzak","year":"2023","journal-title":"Biochim. Biophys. Acta-Mol. Cell Res."},{"key":"10.1016\/j.bioorg.2026.110129_bb0225","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-3-319-91442-8_15","article-title":"Olaparib","author":"Bochum","year":"2018","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110129_bb0230","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nchembio.2236","article-title":"Full antagonism of the estrogen receptor without a prototypical ligand side chain","author":"Srinivasan","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110129_bb0235","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101657118","article-title":"Dual-mechanism estrogen receptor inhibitors","author":"Min","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2026.110129_bb0240","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1021\/acs.jmedchem.4c00196","article-title":"Discovery of novel ERalpha and aromatase dual-targeting PROTAC degraders to overcome endocrine-resistant breast Cancer","author":"Xin","year":"2024","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:45:37Z","timestamp":1787676337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826006656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"alternative-id":["S0045206826006656"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110129","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel ER\u03b1-targeted hydrophobic tag degrader, overcomes tamoxifen resistance via unfolded protein response-induced apoptosis and homologous recombination repair inhibition in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110129"}}